PSTPIP2 and chronic recurrent multifocal osteomyelitis: The mitigation of CRMO symptoms in the DKO mice was also validated by scRNA-seq and flow cytometry analyses using the affected bone marrow (BM) cells from Pstpip2−/− and DKO strains.